| UniProt ID | CTNA2_HUMAN | |
|---|---|---|
| UniProt AC | P26232 | |
| Protein Name | Catenin alpha-2 | |
| Gene Name | CTNNA2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 953 | |
| Subcellular Localization |
Cell membrane Peripheral membrane protein Cytoplasmic side . Cytoplasm . Cytoplasm, cytoskeleton . Cell junction, adherens junction . Cell projection, axon . Nucleus . |
|
| Protein Description | May function as a linker between cadherin adhesion receptors and the cytoskeleton to regulate cell-cell adhesion and differentiation in the nervous system. Regulates morphological plasticity of synapses and cerebellar and hippocampal lamination during development. Functions in the control of startle modulation.. | |
| Protein Sequence | MTSATSPIILKWDPKSLEIRTLTVERLLEPLVTQVTTLVNTSNKGPSGKKKGRSKKAHVLAASVEQATQNFLEKGEQIAKESQDLKEELVAAVEDVRKQGETMRIASSEFADDPCSSVKRGTMVRAARALLSAVTRLLILADMADVMRLLSHLKIVEEALEAVKNATNEQDLANRFKEFGKEMVKLNYVAARRQQELKDPHCRDEMAAARGALKKNATMLYTASQAFLRHPDVAATRANRDYVFKQVQEAIAGISNAAQATSPTDEAKGHTGIGELAAALNEFDNKIILDPMTFSEARFRPSLEERLESIISGAALMADSSCTRDDRRERIVAECNAVRQALQDLLSEYMNNTGRKEKGDPLNIAIDKMTKKTRDLRRQLRKAVMDHISDSFLETNVPLLVLIEAAKSGNEKEVKEYAQVFREHANKLVEVANLACSISNNEEGVKLVRMAATQIDSLCPQVINAALTLAARPQSKVAQDNMDVFKDQWEKQVRVLTEAVDDITSVDDFLSVSENHILEDVNKCVIALQEGDVDTLDRTAGAIRGRAARVIHIINAEMENYEAGVYTEKVLEATKLLSETVMPRFAEQVEVAIEALSANVPQPFEENEFIDASRLVYDGVRDIRKAVLMIRTPEELEDDSDFEQEDYDVRSRTSVQTEDDQLIAGQSARAIMAQLPQEEKAKIAEQVEIFHQEKSKLDAEVAKWDDSGNDIIVLAKQMCMIMMEMTDFTRGKGPLKNTSDVINAAKKIAEAGSRMDKLARAVADQCPDSACKQDLLAYLQRIALYCHQLNICSKVKAEVQNLGGELIVSGTGVQSTFTTFYEVDCDVIDGGRASQLSTHLPTCAEGAPIGSGSSDSSMLDSATSLIQAAKNLMNAVVLTVKASYVASTKYQKVYGTAAVNSPVVSWKMKAPEKKPLVKREKPEEFQTRVRRGSQKKHISPVQALSEFKAMDSF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTSATSPII ------CCCCCCCEE | 27.37 | 20068231 | |
| 2 (in isoform 2) | Phosphorylation | - | 27.37 | - | |
| 3 | Phosphorylation | -----MTSATSPIIL -----CCCCCCCEEE | 28.40 | 20068231 | |
| 3 (in isoform 2) | Phosphorylation | - | 28.40 | - | |
| 5 | Phosphorylation | ---MTSATSPIILKW ---CCCCCCCEEEEC | 34.50 | 20068231 | |
| 6 | Phosphorylation | --MTSATSPIILKWD --CCCCCCCEEEECC | 17.51 | 20068231 | |
| 6 (in isoform 2) | Phosphorylation | - | 17.51 | - | |
| 15 (in isoform 1) | Ubiquitination | - | 66.26 | 21906983 | |
| 15 | Ubiquitination | IILKWDPKSLEIRTL EEEECCCCCCEEEEE | 66.26 | 21890473 | |
| 16 | Phosphorylation | ILKWDPKSLEIRTLT EEECCCCCCEEEEEE | 36.30 | 24719451 | |
| 33 | Phosphorylation | RLLEPLVTQVTTLVN HHHHHHHHHHHHHHC | 25.63 | 23403867 | |
| 36 | Phosphorylation | EPLVTQVTTLVNTSN HHHHHHHHHHHCCCC | 12.47 | 28857561 | |
| 37 | Phosphorylation | PLVTQVTTLVNTSNK HHHHHHHHHHCCCCC | 29.83 | 28857561 | |
| 41 | Phosphorylation | QVTTLVNTSNKGPSG HHHHHHCCCCCCCCC | 26.63 | 23403867 | |
| 42 (in isoform 2) | Phosphorylation | - | 31.19 | 27251275 | |
| 42 | Phosphorylation | VTTLVNTSNKGPSGK HHHHHCCCCCCCCCC | 31.19 | 25849741 | |
| 49 (in isoform 2) | Ubiquitination | - | 56.50 | 21906983 | |
| 80 | Ubiquitination | EKGEQIAKESQDLKE HHHHHHHHHCHHHHH | 60.57 | - | |
| 132 | Phosphorylation | RAARALLSAVTRLLI HHHHHHHHHHHHHHH | 22.88 | 22817900 | |
| 135 | Phosphorylation | RALLSAVTRLLILAD HHHHHHHHHHHHHHH | 18.47 | 22817900 | |
| 151 | Phosphorylation | ADVMRLLSHLKIVEE HHHHHHHHHHHHHHH | 31.22 | 20068231 | |
| 151 (in isoform 2) | Phosphorylation | - | 31.22 | - | |
| 218 | Phosphorylation | GALKKNATMLYTASQ HHHHHCHHHEEEHHH | 19.66 | 23532336 | |
| 255 | Phosphorylation | QEAIAGISNAAQATS HHHHHHHCCHHHCCC | 21.35 | 25307156 | |
| 261 | Phosphorylation | ISNAAQATSPTDEAK HCCHHHCCCCCHHHC | 24.14 | 25072903 | |
| 262 (in isoform 2) | Phosphorylation | - | 28.90 | 24719451 | |
| 262 | Phosphorylation | SNAAQATSPTDEAKG CCHHHCCCCCHHHCC | 28.90 | 15345747 | |
| 264 | Phosphorylation | AAQATSPTDEAKGHT HHHCCCCCHHHCCCC | 46.36 | 25072903 | |
| 302 | Phosphorylation | SEARFRPSLEERLES CCHHCCCCHHHHHHH | 44.12 | 20860994 | |
| 309 | Phosphorylation | SLEERLESIISGAAL CHHHHHHHHHHHHHH | 29.79 | 27251275 | |
| 320 | Phosphorylation | GAALMADSSCTRDDR HHHHHCCCCCCCCHH | 20.13 | 25850435 | |
| 321 | Phosphorylation | AALMADSSCTRDDRR HHHHCCCCCCCCHHH | 21.76 | 25850435 | |
| 322 | Glutathionylation | ALMADSSCTRDDRRE HHHCCCCCCCCHHHH | 4.13 | 22555962 | |
| 323 | Phosphorylation | LMADSSCTRDDRRER HHCCCCCCCCHHHHH | 38.80 | 25850435 | |
| 415 | Malonylation | SGNEKEVKEYAQVFR CCCHHHHHHHHHHHH | 46.21 | 26320211 | |
| 415 | Ubiquitination | SGNEKEVKEYAQVFR CCCHHHHHHHHHHHH | 46.21 | - | |
| 417 | Phosphorylation | NEKEVKEYAQVFREH CHHHHHHHHHHHHHH | 9.16 | 28152594 | |
| 437 | Phosphorylation | EVANLACSISNNEEG HHHHHHHHCCCCHHH | 24.36 | - | |
| 475 | Phosphorylation | TLAARPQSKVAQDNM HHHHCCCCHHHHCCH | 31.60 | 24076635 | |
| 535 | Phosphorylation | LQEGDVDTLDRTAGA ECCCCCHHHHHHHHH | 30.33 | 24117733 | |
| 578 | Phosphorylation | LEATKLLSETVMPRF HHHHHHHCCCCHHHH | 41.48 | 25599653 | |
| 580 | Phosphorylation | ATKLLSETVMPRFAE HHHHHCCCCHHHHHH | 20.80 | 25599653 | |
| 621 | Methylation | RLVYDGVRDIRKAVL HHHHHHHHHHHHHHH | 38.89 | - | |
| 632 | Phosphorylation | KAVLMIRTPEELEDD HHHHCCCCHHHHCCC | 24.91 | 25072903 | |
| 640 (in isoform 2) | Phosphorylation | - | 57.42 | 24719451 | |
| 640 | Phosphorylation | PEELEDDSDFEQEDY HHHHCCCCCCCHHHC | 57.42 | 22617229 | |
| 647 | Phosphorylation | SDFEQEDYDVRSRTS CCCCHHHCCHHCCCC | 18.65 | 30177828 | |
| 651 | Phosphorylation | QEDYDVRSRTSVQTE HHHCCHHCCCCEECC | 39.49 | 19664994 | |
| 653 (in isoform 2) | Phosphorylation | - | 34.20 | - | |
| 653 | Phosphorylation | DYDVRSRTSVQTEDD HCCHHCCCCEECCCC | 34.20 | 29255136 | |
| 654 (in isoform 2) | Phosphorylation | - | 15.89 | - | |
| 654 | Phosphorylation | YDVRSRTSVQTEDDQ CCHHCCCCEECCCCC | 15.89 | 19664994 | |
| 657 | Phosphorylation | RSRTSVQTEDDQLIA HCCCCEECCCCCCCC | 38.95 | 19664994 | |
| 667 | Phosphorylation | DQLIAGQSARAIMAQ CCCCCHHHHHHHHHC | 20.85 | 23927012 | |
| 696 | Ubiquitination | IFHQEKSKLDAEVAK HHHHHHHHHHHHHHH | 62.55 | - | |
| 726 | Phosphorylation | CMIMMEMTDFTRGKG HHHHHHHCCCCCCCC | 18.04 | 24043423 | |
| 729 | Phosphorylation | MMEMTDFTRGKGPLK HHHHCCCCCCCCCCC | 41.12 | 24043423 | |
| 738 | Phosphorylation | GKGPLKNTSDVINAA CCCCCCCHHHHHHHH | 25.39 | - | |
| 739 | Phosphorylation | KGPLKNTSDVINAAK CCCCCCHHHHHHHHH | 38.99 | - | |
| 753 | Phosphorylation | KKIAEAGSRMDKLAR HHHHHHHHHHHHHHH | 31.32 | 21406692 | |
| 768 (in isoform 3) | Phosphorylation | - | 57.40 | 22210691 | |
| 770 (in isoform 3) | Phosphorylation | - | 16.35 | 22210691 | |
| 771 (in isoform 3) | Phosphorylation | - | 4.75 | 22210691 | |
| 778 | Phosphorylation | CKQDLLAYLQRIALY HHHHHHHHHHHHHHH | 11.88 | - | |
| 786 (in isoform 3) | Phosphorylation | - | 1.39 | 22210691 | |
| 853 (in isoform 2) | Phosphorylation | - | 32.44 | - | |
| 853 | Phosphorylation | GAPIGSGSSDSSMLD CCCCCCCCCCHHHHH | 32.44 | 15345747 | |
| 889 | Ubiquitination | ASYVASTKYQKVYGT HHHHHCCCCEEEECC | 43.09 | - | |
| 889 | Acetylation | ASYVASTKYQKVYGT HHHHHCCCCEEEECC | 43.09 | 19608861 | |
| 891 (in isoform 2) | Phosphorylation | - | 30.23 | 24719451 | |
| 901 | Phosphorylation | YGTAAVNSPVVSWKM ECCCCCCCCEEECCC | 16.69 | 15345747 | |
| 939 | Phosphorylation | GSQKKHISPVQALSE CCCCCCCCHHHHHHH | 20.81 | 20886841 | |
| 945 | Phosphorylation | ISPVQALSEFKAMDS CCHHHHHHHHHHHCC | 43.96 | 20860994 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CTNA2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CTNA2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CTNA2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CTNB1_HUMAN | CTNNB1 | physical | 26344197 | |
| PLAK_HUMAN | JUP | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-889, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151, AND MASSSPECTROMETRY. | |